These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3940248)

  • 1. Interferon in chronic hepatitis B.
    Gregory PB
    Gastroenterology; 1986 Jan; 90(1):237-40. PubMed ID: 3940248
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic hepatitis B and C with alpha interferon].
    Hess G
    Z Gastroenterol Verh; 1991 Mar; 26():149-51. PubMed ID: 1714130
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. Preliminary results.
    Barbara L; Mazzella G; Baraldini M; Gasbarrini G; Giungi F; Malavolti M; Mastroroberto L; Miglio F; Roda E; Raise E
    J Hepatol; 1986; 3 Suppl 2():S235-8. PubMed ID: 3298411
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection: patients' tolerance and the effect on viral markers.
    Bissett J; Eisenberg M; Gregory P; Robinson WS; Merigan TC
    J Infect Dis; 1988 May; 157(5):1076-80. PubMed ID: 3129521
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 28 consecutive days lymphoblastoid interferon (alpha-IFN) administration on hepatitis B virus related chronic liver disease.
    Franco A; Barnaba V; Levrero M; Ruberti G; Van Dyke A; Bonavita MS; Balsano F
    J Hepatol; 1986; 3 Suppl 2():S239-43. PubMed ID: 3298412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permanent inhibition of viral replication induced by low dosage of human leukocyte interferon in patients with chronic hepatitis B.
    Pastore G; Santantonio T; Monno L; Milella M; Luchena N; Angarano G
    Hepatogastroenterology; 1988 Apr; 35(2):57-61. PubMed ID: 3371847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membranous glomerulonephritis and chronic persistent hepatitis B in a child: treatment with recombinant interferon alfa.
    Jonas MM; Ragin L; Silva MO
    J Pediatr; 1991 Nov; 119(5):818-20. PubMed ID: 1941393
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.
    Anderson MG; Harrison TJ; Alexander GJ; Zuckerman AJ; Murray-Lyon IM
    J Hepatol; 1986; 3 Suppl 2():S225-7. PubMed ID: 3298409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of reaferon and antioxidants in children with chronic hepatitis].
    Frolov VM; Peresadin NA; Sidorova VS; Germanov VT; Pustovoĭ IuG
    Pediatriia; 1992; (4-6):60-2. PubMed ID: 1408577
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
    Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoblastoid alpha-interferon weekly, daily and combined with acyclovir for chronic HBeAg-positive hepatitis.
    Schalm SW; Heytink RA; Van Buuren HR; De Man RA
    J Hepatol; 1986; 3 Suppl 2():S189-92. PubMed ID: 3598156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyclovir, oral, intravenous and combined with interferon for chronic HBeAg-positive hepatitis.
    Schalm SW; Heytink RA; Van Buuren HR; De Man RA
    J Hepatol; 1986; 3 Suppl 2():S137-41. PubMed ID: 3598154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history and therapy of chronic hepatitis B virus infection.
    Alexander GJ; Williams R
    Am J Med; 1988 Aug; 85(2A):143-6. PubMed ID: 3044078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic hepatitis B in children with recombinant alfa interferon. Different response according to age at infection.
    Bruguera M; Amat L; Garcia O; Lambruschini N; Carnicer J; Bergada A; Martin Orte E; Costa J; Sanchez-Tapias JM; Rodés J
    J Clin Gastroenterol; 1993 Dec; 17(4):296-9. PubMed ID: 8308214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin M antibody to hepatitis B core antigen (IgM anti-HBc) as a marker of interferon therapy in patients with persistent hepatitis B virus infection.
    Nakajima E; Tsuji T; Kachi K; Kagawa K; Okanoue T; Takino T; Yamada A; Imanishi J
    Biken J; 1987 Mar; 30(1):17-23. PubMed ID: 3675547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune effects of alpha-interferon in chronic liver disease.
    Peters M; Walling DM; Waggoner J; Avigan MI; Sjogren M; Hoofnagle JH
    J Hepatol; 1986; 3 Suppl 2():S283-9. PubMed ID: 3598159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
    Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
    Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral therapy in hepatitis B infection.
    Thomas HC; Scully LJ
    Br Med Bull; 1985 Oct; 41(4):374-80. PubMed ID: 3902143
    [No Abstract]   [Full Text] [Related]  

  • 19. Extracorporeal immunomodulation in chronic hepatitis type B with double filtration plasmapheresis.
    Fujikawa M; Tomita A; Nakata S; Matuura Y; Azechi H; Saibara T; Onishi S; Yamamoto Y
    Prog Clin Biol Res; 1990; 337():341-4. PubMed ID: 2352990
    [No Abstract]   [Full Text] [Related]  

  • 20. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection.
    Alexander GJ; Brahm J; Fagan EA; Smith HM; Daniels HM; Eddleston AL; Williams R
    Lancet; 1987 Jul; 2(8550):66-9. PubMed ID: 2885573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.